The impact when T1Diabetes enters your life

Like most parents of a newly diagnosed child Jane Bewick Green was totally unprepared for what was to follow.

Her outstanding account of the diagnosis and the day to day management of the condition will strike a chord with many parents.

More than this, the profits will go to JDRF.

Follow this link if you have a Kindle, a heart  and 86p to spare!

JDRF London to Paris 9-11 June 2011

John Jocham and Rich Preston are taking part in this year’s London to Paris Bike ride to raise funds for research and awareness of type 1 diabetes.

If you feel able to sponsor us please click here to make a donation.


John and Rich



UPDATE……… We made it! Thanks to everyone for your support.

Type I diabetes ‘missed in thousands of children’

Thousands of children with Type I diabetes are not being diagnosed until they have suffered from a life-threatening ‘warning sign’, doctors say today .

Stephen Adams

By Stephen Adams,Daily Telegraph Medical Correspondent 6:30AM GMT 18 Feb 2011 

A quarter of the 29,000 children with Type I diabetes in Britain are only diagnosed because they have an attack of Diabetic Ketoacidosis, or DKA, according to Dr Julie Edge, a consultant paediatric diabetologist at the John Radcliffe Hospital in Oxford.

DKA, which usually only occurs when Type I diabetes is fully Read the rest of this entry »

HbA1c levels change with the seasons


snow_210x157An interesting new research study has found evidence that Polish children with type 1 diabetes, aged between 7 and 18 years old, experience seasonal fluctuations in their HbA1c levels.

Recently published in the scientific journal Diabetologia, the study found the highest HbA1c levels during February, November and December, whilst August and September showed the lowest levels. All HbA1c measurements from 677 children and young people under 18 years old were tracked for a three year period. The research team found that levels varied throughout the year by approximately 0.5% (18 mmol/mol). Interestingly, no significant variations were observed in the records of children aged 7 and under.

Weather patterns were recorded over the same period, showing that seasonal temperature and sunshine levels follow a similar pattern to changing HbA1c levels. Although it is tempting to draw conclusions from this correlation, this research does not tell us why the HbA1c levels might be affected.

To answer this question, the researchers involved are keen to point to previous studies linking increased exercise to lower HbA1c levels. As children in colder climates are less active in the winter months, they could be at risk of increased HbA1c levels in the winter. However the effect could also be attributed to other factors, including vitamin D deficiency (as sunshine is needed to synthesise vitamin D in the skin) or to weather independent factors such as school stress, seasonal infections, or diet.

Rachel Connor, Head of Research Communications said: “This research offers an interesting insight into factors that may affect HbA1c levels. Good blood glucose control is vital to prevent complications later in life, which is why JDRF is investing in research to help make this as easy as possible for people with type 1 diabetes. 

This is not the first time that scientists have investigated seasonal changes in type 1 diabetes. Research has shown evidence of seasonal variations in HbA1c levels in adults, although not previously in children. Furthermore, in August 2009 JDRF reported on an international study describing seasonal patterns in the rate of type 1 diagnosis. Countries with greater seasonal temperature variations experienced a peak in type 1 diagnoses in winter.

UT Southwestern’s new diabetes study offers promise to Type 1 patients

Researchers at UT Southwestern Medical Center at Dallas are studying a new treatment for Type 1 diabetes that they hope will be a major step forward in the management of the disease, which affects the daily lives and lifelong health of millions of people.

The study is funded by Juvenile Diabetes Research Foundation and Amylin Pharmaceuticals.

UT Southwestern physicians leading the study said Tuesday that they have been able to control levels of blood glucose in animals using metreleptin, a synthetic version of the human hormone leptin. Read the rest of this entry »

JDRF Launches new petition for increased government funding


JDRF PetitionJuvenile Diabetes Research Foundation, the leading charitable funder of type 1 diabetes research in the world, is currently campaigning for increased levels of government funding to be given for type 1 research.

Please sign their petition and show your support.

CLICK HERE to be directed to the petition

Team Crusaders complete London to Paris Challenge.

The team set off cycling from London’s Crystal Palace on a gloomy friday morning and were celebrating under the Eiffel Tower in Paris on the Sunday afternoon raising over £12,000 for JDRF in the process. Thanks to everyone for supporting and sponsoring us.


Nigel Added a couple more video’s of us actually cycling rather than just enjoying ourselves! Sorry about the lack of sound on the first one – sort it out Nige!!

Adrian Sanders MP puts down Early Day Motion for JDRF

JDRF recently met with Adrian Sanders MP, Liberal Democrat Member of Parliament for Torbay. Mr Sanders agreed to put down an Early Day Motion for JDRF in order to increase awareness and understanding about type 1 diabetes.

Early Day Motions provide a formal mechanism for MPs to raise issues in the House of Commons. You can see the text of the motion here. Please get in contact with your MP and ask them to sign EDM 122 and give their support for this motion.

You can find your MP by clicking here.

New research may suggest another role for a molecule to help prevent heart damage

Scientists have some evidence that a molecule called C-peptide may help prevent some of the cardiovascular complications that people with diabetes are at risk from.

Researchers from the University of Leeds found that a naturally occurring substance, C-peptide, may Read the rest of this entry »

A positive step forward for diabetes research

The drug otelixizumab appears to halt the rapid decline in the body’s production of insulin, according to a recent study published in the journal ‘Diabetologia’. This rapid decline of insulin production occurs in people with Type 1 diabetes due to an auto-immune response.

The drug works by switching off the immune system’s self-destruct mechanism that causes Read the rest of this entry »